| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |